Sars-CoV-2 Infection in a Neutropenic Pediatric Patient with Leukemia:
Addressing the need for universal guidelines for treatment of Sars-CoV-2
positive, immunocompromised patients
Abstract
In December 2019, a novel coronavirus (Sars-CoV-2 ) emerged from Wuhan,
Hubei province, China, and has spread worldwide, with more than 4
million confirmed cases[1,2,3]. Available literature on the clinical
characteristics and natural history of pediatric patients infected with
Sars-CoV-2 is limited and less has been established regarding guidelines
for the treatment of immunocompromised pediatric patients. This is a
case report on the clinical course and management of a 6 year old female
with acute lymphoblastic lymphoma with Sars-CoV-2. The goal is to
highlight the need for management guidelines in the care of pediatric
cancer patients with Sars-CoV-2.
